换一批
第一作者：
Russell W,Jenkins
第一单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
作者：
Russell W,Jenkins [1]
;
Amir R,Aref [2]
;
Patrick H,Lizotte [2]
;
Elena,Ivanova [2]
;
Susanna,Stinson [3]
;
Chensheng W,Zhou [4]
;
Michaela,Bowden [4]
;
Jiehui,Deng [5]
;
Hongye,Liu [6]
;
Diana,Miao [7]
;
Meng Xiao,He [8]
;
William,Walker [2]
;
Gao,Zhang [9]
;
Tian,Tian [10]
;
Chaoran,Cheng [10]
;
Zhi,Wei [10]
;
Sangeetha,Palakurthi [2]
;
Mark,Bittinger [2]
;
Hans,Vitzthum [11]
;
Jong Wook,Kim [7]
;
Ashley,Merlino [5]
;
Max,Quinn [5]
;
Chandrasekar,Venkataramani [3]
;
Joshua A,Kaplan [3]
;
Andrew,Portell [2]
;
Prafulla C,Gokhale [2]
;
Bart,Phillips [3]
;
Alicia,Smart [7]
;
Asaf,Rotem [5]
;
Robert E,Jones [2]
;
Lauren,Keogh [2]
;
Maria,Anguiano [12]
;
Lance,Stapleton [3]
;
Zhiheng,Jia [3]
;
Michal,Barzily-Rokni [11]
;
Israel,Cañadas [5]
;
Tran C,Thai [5]
;
Marc R,Hammond [11]
;
Raven,Vlahos [4]
;
Eric S,Wang [13]
;
Hua,Zhang [5]
;
Shuai,Li [5]
;
Glenn J,Hanna [5]
;
Wei,Huang [2]
;
Mai P,Hoang [14]
;
Adriano,Piris [15]
;
Jean-Pierre,Eliane [14]
;
Anat O,Stemmer-Rachamimov [14]
;
Lisa,Cameron [16]
;
Mei-Ju,Su [5]
;
Parin,Shah [5]
;
Benjamin,Izar [7]
;
Manisha,Thakuria [17]
;
Nicole R,LeBoeuf [17]
;
Guilherme,Rabinowits [5]
;
Viswanath,Gunda [18]
;
Sareh,Parangi [18]
;
James M,Cleary [5]
;
Brian C,Miller [5]
;
Shunsuke,Kitajima [5]
;
Rohit,Thummalapalli [5]
;
Benchun,Miao [11]
;
Thanh U,Barbie [19]
;
Vivek,Sivathanu [20]
;
Joshua,Wong [5]
;
William G,Richards [21]
;
Raphael,Bueno [21]
;
Charles H,Yoon [19]
;
Juan,Miret [2]
;
Meenhard,Herlyn [9]
;
Levi A,Garraway [5]
;
Eliezer M,Van Allen [7]
;
Gordon J,Freeman [5]
;
Paul T,Kirschmeier [2]
;
Jochen H,Lorch [5]
;
Patrick A,Ott [5]
;
F Stephen,Hodi [5]
;
Keith T,Flaherty [11]
;
Roger D,Kamm [22]
;
Genevieve M,Boland [18]
;
Kwok-Kin,Wong [2]
;
David,Dornan [23]
;
Cloud Peter,Paweletz [24]
;
David A,Barbie [25]
作者单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
[1]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
[2]
Gilead Sciences, Foster City, California.
[3]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[4]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[5]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.;Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts.
[6]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
[7]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Broad Institute of Harvard and MIT, Cambridge, Massachusetts.;Harvard Graduate Program in Biophysics, Boston, Massachusetts.
[8]
Melanoma Research Center and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania.
[9]
Department of Computer Science, New Jersey Institute of Technology, Newark, New Jersey.
[10]
Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
[11]
Center for Applied Medical Research, University of Navarra, Pamplona, Spain.
[12]
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[13]
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
[14]
Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
[15]
Confocal and Light Microscopy Core Facility, Dana-Farber Cancer Institute, Boston, Massachusetts.
[16]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
[17]
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
[18]
Department of Surgical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
[19]
Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
[20]
Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
[21]
Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.;Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
[22]
Gilead Sciences, Foster City, California. dbarbie@partners.org CloudP_Paweletz@dfci.harvard.edu David.Dornan@gilead.com.
[23]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. dbarbie@partners.org CloudP_Paweletz@dfci.harvard.edu David.Dornan@gilead.com.;Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
[24]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. dbarbie@partners.org CloudP_Paweletz@dfci.harvard.edu David.Dornan@gilead.com.
[25]
医学主题词
动物(Animals);细胞培养技术(Cell Culture Techniques);细胞系, 肿瘤(Cell Line, Tumor);细胞因子类(Cytokines);抗药性, 肿瘤(Drug Resistance, Neoplasm);流式细胞术(Flow Cytometry);人类(Humans);免疫组织化学(Immunohistochemistry);免疫表型分型(Immunophenotyping);小鼠(Mice);微流体分析技术(Microfluidic Analytical Techniques);球形体, 细胞(Spheroids, Cellular);延时成像(Time-Lapse Imaging);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1158/2159-8290.CD-17-0833
PMID
29101162
发布时间
2022-04-10
- 浏览24
Cancer discovery
Cancer discovery
196-215页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
